Equivalent Dosing for Metoprolol and Nebivolol

Introduction to Beta-Blocker Conversion

• The European Society of Cardiology recommends a starting dose of 12.5-25 mg once daily for metoprolol succinate in heart failure patients, with a target dose of 200 mg daily 1, 2
• The European Society of Cardiology recommends a starting dose of 1.25 mg once daily for nebivolol in heart failure patients, with a target dose of 10 mg daily 1

Dosing Equivalence and Rationale

• The target dose ratio between metoprolol and nebivolol is approximately 20:1 based on evidence-based dosing 1
• The American Heart Association recommends a target dose of 200 mg daily for metoprolol in heart failure patients 1, 2, 3
• The American Heart Association recommends a target dose of 10 mg daily for nebivolol in heart failure patients 1

Conversion Protocol

• The European Society of Cardiology recommends tapering metoprolol by 25-50% every 1-2 weeks to avoid rebound hypertension or angina exacerbation 2
• The European Society of Cardiology recommends starting nebivolol 1.25 mg once daily after metoprolol washout 1
• The American College of Cardiology recommends monitoring blood pressure and heart rate within 1-2 weeks after initiating nebivolol 2

Titration Schedule

• The European Society of Cardiology recommends doubling the nebivolol dose every 1-2 weeks if well tolerated, with a progression of 1.25 mg → 2.5 mg → 5 mg → 10 mg daily 1, 3
• The American Heart Association recommends a target resting heart rate of 50-60 beats per minute 2

Monitoring Parameters

• The European Society of Cardiology recommends checking blood pressure and heart rate at each visit during titration 2
• The American College of Cardiology recommends monitoring for signs of worsening heart failure, symptomatic bradycardia, and hypotension 2

Contraindications to Check

• The European Society of Cardiology recommends avoiding nebivolol in patients with decompensated heart failure, second or third-degree heart block, active asthma, or severe reactive airway disease 1, 2
• The American Heart Association recommends avoiding nebivolol in patients with symptomatic bradycardia or hypotension 2